US's first drug priced at more than $1 million may be on the horizon
May 07, 2018 at 13:38 PM EDT
New gene therapies that aim to cure hemophilia, a disease affecting the blood's ability to clot, may carry prices of $1.5 million or more, analysts at Leerink wrote in a research note Monday.
